Longer Omalizumab Use Eases Itch From Chronic Hives Longer Omalizumab Use Eases Itch From Chronic Hives

The quality of life of patients with idiopathic urticaria improved when they stayed on the monoclonal antibody for 48 instead of 24 weeks, the XTEND-CIU study shows.Medscape Medical News

Source: Medscape Medical News Headlines - March 5, 2018 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news